No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Care Facilities
Apollo Hospitals Enterprise Limited, along with its various subsidiaries, operates as a prominent provider of healthcare services, serving patients both within India and internationally. The group strategically divides its business into key segments: Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and other ancillary operations. The company manages a comprehensive network of medical facilities, ranging from primary care centers to secondary hospitals and advanced tertiary care institutions. Its extensive medical offerings cover critical specialties such as cardiac sciences, orthopedics, oncology, neurosciences, emergency care, robotic surgery, and organ transplantation. Furthermore, Apollo's clinical expertise extends across a broad spectrum of disciplines, including cardiology, neurology, gastroenterology, dermatology, ophthalmology, pediatrics, endocrinology, gynecology, urology, nephrology, pulmonology, rheumatology, diverse surgical sub-specialties (like neurosurgery, plastic surgery, vascular surgery), radiology, neonatology, psychiatry, dentistry, and ear, nose, and throat (ENT) services. Beyond direct patient care, the enterprise also engages in a variety of related ventures, encompassing healthcare project consultancy, health insurance provision, managing medical colleges, facilitating e-learning through Medvarsity, and conducting vital research services. Its operational footprint additionally includes pharmacies, a wide array of primary and specialized clinics (such as birthing, fertility, dialysis, diabetes management, and single-specialty centers), diagnostic chains, as well as daycare and home healthcare services. A unique offering is the company's involvement in the bio-banking of tissues. Apollo Hospitals connects with its clientele through multiple channels, including national retail healthcare centers, genomics institutes, its comprehensive digital health platform Apollo 24/7, and the online pharmacy portal, www.apollopharmacy.in. Established in 1979, the company is headquartered in Chennai, India.
www.apollohospitals.comNo one on the platform currently holds APOLLOHOSP.BO.
No tracked institution reports a position in APOLLOHOSP.BO as of their last filing.
No one on the platform has traded APOLLOHOSP.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 12.8% | 29.8% | 26.0% | — | — | — |
| Rev. Growth % | 15.8% | 19.0% | ||||
| Profit Margin % | 7.7% | 6.2% | 4.4% | |||
| Free Cash Flow Margin % | 2.8% | 3.2% | 3.1% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $300.5B | +19.5% | $171.82 | $151.54–$181.89 | — | 24 |
| 2028 | $359.1B | +19.5% | $219.92 | $189.34–$254.78 | — | 25 |
| 2029 | $408.0B | +13.6% | $275.82 | $251.87–$331.59 | — | 14 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 6 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-12 | $38.93 | $40.40 | +3.8% |
| 2026-05-20 | $33.35 | $36.80 | +10.3% |
| 2026-02-10 | $33.84 | $35.90 | +6.1% |
| 2025-11-06 | $34.09 | $33.20 | -2.6% |
| 2025-08-12 | $26.49 | $30.10 | +13.6% |
| 2025-05-30 | $27.80 | $27.10 | -2.5% |
| 2025-02-10 | $24.15 | $25.90 | +7.2% |
| 2024-11-06 | $26.16 | $26.34 | +0.7% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| APOLLOHOSP.BOApollo Hospitals Enterprise Limited | $8815.35 | -0.39% | $1.27T | — |
| CIPLA.BOCipla Limited | $1354.50 | -0.77% | $1.10T | — |
| CIPLA.NSCipla Limited | $1356.40 | -0.70% | $1.10T | — |
| FORTIS.BOFortis Healthcare Limited | $884.35 | -0.33% | $656.9B | — |
| FORTIS.NSFortis Healthcare Limited |
| $885.40 |
| -0.27% |
| $668.4B |
| — |
| MANKIND.BOMankind Pharma Limited | $2256.60 | -0.90% | $931.9B | — |
| MANKIND.NSMankind Pharma Limited | $2252.70 | -1.20% | $930.4B | — |
Source: Financial Modeling Prep · peers by sector/industry